CH619458A5 - Process for the preparation of a quinoxaline derivative - Google Patents
Process for the preparation of a quinoxaline derivative Download PDFInfo
- Publication number
- CH619458A5 CH619458A5 CH39276A CH39276A CH619458A5 CH 619458 A5 CH619458 A5 CH 619458A5 CH 39276 A CH39276 A CH 39276A CH 39276 A CH39276 A CH 39276A CH 619458 A5 CH619458 A5 CH 619458A5
- Authority
- CH
- Switzerland
- Prior art keywords
- feed
- formula
- oxide
- quinoxaline
- active ingredient
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 7
- 238000002360 preparation method Methods 0.000 title claims description 4
- 125000001567 quinoxalinyl group Chemical class N1=C(C=NC2=CC=CC=C12)* 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 claims abstract description 21
- 241001465754 Metazoa Species 0.000 claims abstract description 12
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims abstract description 10
- 150000001875 compounds Chemical class 0.000 claims abstract description 7
- 229910021529 ammonia Inorganic materials 0.000 claims abstract description 5
- GCPWJFKTWGFEHH-UHFFFAOYSA-N acetoacetamide Chemical compound CC(=O)CC(N)=O GCPWJFKTWGFEHH-UHFFFAOYSA-N 0.000 claims abstract description 4
- 150000003141 primary amines Chemical class 0.000 claims abstract description 4
- 239000000376 reactant Substances 0.000 claims abstract description 4
- 238000002156 mixing Methods 0.000 claims abstract description 3
- 239000004480 active ingredient Substances 0.000 claims description 16
- CKIHZSGJPSDCNC-UHFFFAOYSA-N Quindoxin Chemical compound C1=CC=C2N([O-])C=C[N+](=O)C2=C1 CKIHZSGJPSDCNC-UHFFFAOYSA-N 0.000 claims description 10
- 241000282887 Suidae Species 0.000 claims description 9
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 claims description 9
- 244000144977 poultry Species 0.000 claims description 9
- -1 Chloroamphenicol Tetracycline Chemical class 0.000 claims description 7
- 241000282849 Ruminantia Species 0.000 claims description 7
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 6
- 239000000243 solution Substances 0.000 claims description 6
- 239000000969 carrier Substances 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- IANQTJSKSUMEQM-UHFFFAOYSA-N 1-benzofuran Chemical compound C1=CC=C2OC=CC2=C1 IANQTJSKSUMEQM-UHFFFAOYSA-N 0.000 claims description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 4
- GPTXWRGISTZRIO-UHFFFAOYSA-N chlorquinaldol Chemical compound ClC1=CC(Cl)=C(O)C2=NC(C)=CC=C21 GPTXWRGISTZRIO-UHFFFAOYSA-N 0.000 claims description 4
- WKSAUQYGYAYLPV-UHFFFAOYSA-N pyrimethamine Chemical compound CCC1=NC(N)=NC(N)=C1C1=CC=C(Cl)C=C1 WKSAUQYGYAYLPV-UHFFFAOYSA-N 0.000 claims description 4
- QJBZDBLBQWFTPZ-UHFFFAOYSA-N pyrrolnitrin Chemical compound [O-][N+](=O)C1=C(Cl)C=CC=C1C1=CNC=C1Cl QJBZDBLBQWFTPZ-UHFFFAOYSA-N 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 4
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 claims description 4
- IEDVJHCEMCRBQM-UHFFFAOYSA-N trimethoprim Chemical compound COC1=C(OC)C(OC)=CC(CC=2C(=NC(N)=NC=2)N)=C1 IEDVJHCEMCRBQM-UHFFFAOYSA-N 0.000 claims description 4
- 239000000654 additive Substances 0.000 claims description 3
- 239000012442 inert solvent Substances 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 239000008188 pellet Substances 0.000 claims description 3
- ACTOXUHEUCPTEW-BWHGAVFKSA-N 2-[(4r,5s,6s,7r,9r,10r,11e,13e,16r)-6-[(2s,3r,4r,5s,6r)-5-[(2s,4r,5s,6s)-4,5-dihydroxy-4,6-dimethyloxan-2-yl]oxy-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-10-[(2s,5s,6r)-5-(dimethylamino)-6-methyloxan-2-yl]oxy-4-hydroxy-5-methoxy-9,16-dimethyl-2-o Chemical compound O([C@H]1/C=C/C=C/C[C@@H](C)OC(=O)C[C@@H](O)[C@@H]([C@H]([C@@H](CC=O)C[C@H]1C)O[C@H]1[C@@H]([C@H]([C@H](O[C@@H]2O[C@@H](C)[C@H](O)[C@](C)(O)C2)[C@@H](C)O1)N(C)C)O)OC)[C@@H]1CC[C@H](N(C)C)[C@@H](C)O1 ACTOXUHEUCPTEW-BWHGAVFKSA-N 0.000 claims description 2
- YEAICDDXRUOCKJ-UHFFFAOYSA-N 4-amino-n-pyrazin-2-ylbenzenesulfonamide Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=CN=CC=N1 YEAICDDXRUOCKJ-UHFFFAOYSA-N 0.000 claims description 2
- PMYJGTWUVVVOFO-UHFFFAOYSA-N 4-phenyl-3-furoxancarbonitrile Chemical compound N#CC1=[N+]([O-])ON=C1C1=CC=CC=C1 PMYJGTWUVVVOFO-UHFFFAOYSA-N 0.000 claims description 2
- YVQVOQKFMFRVGR-VGOFMYFVSA-N 5-(morpholin-4-ylmethyl)-3-[(e)-(5-nitrofuran-2-yl)methylideneamino]-1,3-oxazolidin-2-one Chemical compound O1C([N+](=O)[O-])=CC=C1\C=N\N1C(=O)OC(CN2CCOCC2)C1 YVQVOQKFMFRVGR-VGOFMYFVSA-N 0.000 claims description 2
- XDWLRMBWIWKFNC-UHFFFAOYSA-N 6-[2-(5-nitrofuran-2-yl)ethenyl]pyridazin-3-amine Chemical group N1=NC(N)=CC=C1C=CC1=CC=C([N+]([O-])=O)O1 XDWLRMBWIWKFNC-UHFFFAOYSA-N 0.000 claims description 2
- 229910002012 Aerosil® Inorganic materials 0.000 claims description 2
- 239000005995 Aluminium silicate Substances 0.000 claims description 2
- 108010001478 Bacitracin Proteins 0.000 claims description 2
- UNPHELZBWWIXCX-UHFFFAOYSA-N CC1=NC(NS)=NC=C1 Chemical group CC1=NC(NS)=NC=C1 UNPHELZBWWIXCX-UHFFFAOYSA-N 0.000 claims description 2
- 235000008733 Citrus aurantifolia Nutrition 0.000 claims description 2
- QCDFBFJGMNKBDO-UHFFFAOYSA-N Clioquinol Chemical compound C1=CN=C2C(O)=C(I)C=C(Cl)C2=C1 QCDFBFJGMNKBDO-UHFFFAOYSA-N 0.000 claims description 2
- 239000004181 Flavomycin Substances 0.000 claims description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 2
- OJMMVQQUTAEWLP-UHFFFAOYSA-N Lincomycin Natural products CN1CC(CCC)CC1C(=O)NC(C(C)O)C1C(O)C(O)C(O)C(SC)O1 OJMMVQQUTAEWLP-UHFFFAOYSA-N 0.000 claims description 2
- 241000237536 Mytilus edulis Species 0.000 claims description 2
- QLGMTHKWXUANCP-UHFFFAOYSA-N N-(3,4-dimethyl-1,2-oxazol-5-yl)thiohydroxylamine Chemical group CC1=NOC(NS)=C1C QLGMTHKWXUANCP-UHFFFAOYSA-N 0.000 claims description 2
- 229930193140 Neomycin Natural products 0.000 claims description 2
- 229930182555 Penicillin Natural products 0.000 claims description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 claims description 2
- 239000004187 Spiramycin Substances 0.000 claims description 2
- 229920002472 Starch Polymers 0.000 claims description 2
- 239000004098 Tetracycline Substances 0.000 claims description 2
- 229930185202 Thiopeptin Natural products 0.000 claims description 2
- IXEQUEFFDUXSRS-UGJHNBEYSA-N Thiopeptin Bb Natural products CC=C1NC(=O)[C@@H](NC(=O)c2csc(n2)[C@]34CCC(=N[C@@H]3c5csc(n5)[C@@H](NC(=S)c6csc(n6)[C@H](NC(=O)[C@@H]7CN=C1S7)[C@@](C)(O)[C@H](C)O)[C@H](C)OC(=O)c8cc([C@@H](C)O)c9C=C[C@@H](N[C@H](C(C)C)C(=O)N[C@H](C)C(=O)NC(=C)C(=O)N[C@H](C)C(=O)N4)[C@@H](O)c9n8)c%10nc(cs%10)C(=O)NC(=C)C(=O)NC(=C)C(=O)O)[C@H](C)O IXEQUEFFDUXSRS-UGJHNBEYSA-N 0.000 claims description 2
- 235000011941 Tilia x europaea Nutrition 0.000 claims description 2
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 claims description 2
- 239000004182 Tylosin Substances 0.000 claims description 2
- 229930194936 Tylosin Natural products 0.000 claims description 2
- 235000012211 aluminium silicate Nutrition 0.000 claims description 2
- 239000003242 anti bacterial agent Substances 0.000 claims description 2
- 229940088710 antibiotic agent Drugs 0.000 claims description 2
- 229960003071 bacitracin Drugs 0.000 claims description 2
- 229930184125 bacitracin Natural products 0.000 claims description 2
- CLKOFPXJLQSYAH-ABRJDSQDSA-N bacitracin A Chemical compound C1SC([C@@H](N)[C@@H](C)CC)=N[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]1C(=O)N[C@H](CCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2N=CNC=2)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCCCC1 CLKOFPXJLQSYAH-ABRJDSQDSA-N 0.000 claims description 2
- PERZMHJGZKHNGU-JGYWJTCASA-N bambermycin Chemical compound O([C@H]1[C@H](NC(C)=O)[C@@H](O)[C@@H]([C@H](O1)CO[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@@H]1O[C@@H]([C@H]([C@H](O)[C@H]1NC(C)=O)O[C@H]1[C@@H]([C@@H](O)[C@@H](O)[C@H](O1)C(=O)NC=1C(CCC=1O)=O)O)C)[C@H]1[C@@H](OP(O)(=O)OC[C@@H](OC\C=C(/C)CC\C=C\C(C)(C)CCC(=C)C\C=C(/C)CCC=C(C)C)C(O)=O)O[C@H](C(O)=O)[C@@](C)(O)[C@@H]1OC(N)=O PERZMHJGZKHNGU-JGYWJTCASA-N 0.000 claims description 2
- 230000009286 beneficial effect Effects 0.000 claims description 2
- 239000002775 capsule Substances 0.000 claims description 2
- LDBTVAXGKYIFHO-UHFFFAOYSA-N diaveridine Chemical group C1=C(OC)C(OC)=CC=C1CC1=CN=C(N)N=C1N LDBTVAXGKYIFHO-UHFFFAOYSA-N 0.000 claims description 2
- 239000000839 emulsion Substances 0.000 claims description 2
- DANUORFCFTYTSZ-UHFFFAOYSA-N epinigericin Natural products O1C2(C(CC(C)(O2)C2OC(C)(CC2)C2C(CC(O2)C2C(CC(C)C(O)(CO)O2)C)C)C)C(C)C(OC)CC1CC1CCC(C)C(C(C)C(O)=O)O1 DANUORFCFTYTSZ-UHFFFAOYSA-N 0.000 claims description 2
- 235000019374 flavomycin Nutrition 0.000 claims description 2
- 235000013312 flour Nutrition 0.000 claims description 2
- PLHJDBGFXBMTGZ-UHFFFAOYSA-N furazolidone Chemical compound O1C([N+](=O)[O-])=CC=C1C=NN1C(=O)OCC1 PLHJDBGFXBMTGZ-UHFFFAOYSA-N 0.000 claims description 2
- 229960001625 furazolidone Drugs 0.000 claims description 2
- PLHJDBGFXBMTGZ-WEVVVXLNSA-N furazolidone Chemical compound O1C([N+](=O)[O-])=CC=C1\C=N\N1C(=O)OCC1 PLHJDBGFXBMTGZ-WEVVVXLNSA-N 0.000 claims description 2
- 238000002347 injection Methods 0.000 claims description 2
- 239000007924 injection Substances 0.000 claims description 2
- 239000008101 lactose Substances 0.000 claims description 2
- 239000004571 lime Substances 0.000 claims description 2
- OJMMVQQUTAEWLP-KIDUDLJLSA-N lincomycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@@H](C)O)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 OJMMVQQUTAEWLP-KIDUDLJLSA-N 0.000 claims description 2
- 229960005287 lincomycin Drugs 0.000 claims description 2
- 235000020638 mussel Nutrition 0.000 claims description 2
- 229960004927 neomycin Drugs 0.000 claims description 2
- DANUORFCFTYTSZ-BIBFWWMMSA-N nigericin Chemical compound C([C@@H]1C[C@H]([C@H]([C@]2([C@@H](C[C@](C)(O2)C2O[C@@](C)(CC2)C2[C@H](CC(O2)[C@@H]2[C@H](C[C@@H](C)[C@](O)(CO)O2)C)C)C)O1)C)OC)[C@H]1CC[C@H](C)C([C@@H](C)C(O)=O)O1 DANUORFCFTYTSZ-BIBFWWMMSA-N 0.000 claims description 2
- IAIWVQXQOWNYOU-FPYGCLRLSA-N nitrofural Chemical compound NC(=O)N\N=C\C1=CC=C([N+]([O-])=O)O1 IAIWVQXQOWNYOU-FPYGCLRLSA-N 0.000 claims description 2
- 229960000564 nitrofurantoin Drugs 0.000 claims description 2
- NXFQHRVNIOXGAQ-YCRREMRBSA-N nitrofurantoin Chemical compound O1C([N+](=O)[O-])=CC=C1\C=N\N1C(=O)NC(=O)C1 NXFQHRVNIOXGAQ-YCRREMRBSA-N 0.000 claims description 2
- 229960001907 nitrofurazone Drugs 0.000 claims description 2
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 claims description 2
- IWVCMVBTMGNXQD-PXOLEDIWSA-N oxytetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3[C@H](O)[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-PXOLEDIWSA-N 0.000 claims description 2
- 229940049954 penicillin Drugs 0.000 claims description 2
- IZRPKIZLIFYYKR-UHFFFAOYSA-N phenyltoloxamine Chemical compound CN(C)CCOC1=CC=CC=C1CC1=CC=CC=C1 IZRPKIZLIFYYKR-UHFFFAOYSA-N 0.000 claims description 2
- 239000000843 powder Substances 0.000 claims description 2
- 229960000611 pyrimethamine Drugs 0.000 claims description 2
- YAAWASYJIRZXSZ-UHFFFAOYSA-N pyrimidine-2,4-diamine Chemical compound NC1=CC=NC(N)=N1 YAAWASYJIRZXSZ-UHFFFAOYSA-N 0.000 claims description 2
- 229960002132 pyrrolnitrin Drugs 0.000 claims description 2
- OMLXVJIPSAWGRY-UHFFFAOYSA-N s-pyrazin-2-ylthiohydroxylamine Chemical group NSC1=CN=CC=N1 OMLXVJIPSAWGRY-UHFFFAOYSA-N 0.000 claims description 2
- WKEDVNSFRWHDNR-UHFFFAOYSA-N salicylanilide Chemical class OC1=CC=CC=C1C(=O)NC1=CC=CC=C1 WKEDVNSFRWHDNR-UHFFFAOYSA-N 0.000 claims description 2
- FNXKBSAUKFCXIK-UHFFFAOYSA-M sodium;hydrogen carbonate;8-hydroxy-7-iodoquinoline-5-sulfonic acid Chemical class [Na+].OC([O-])=O.C1=CN=C2C(O)=C(I)C=C(S(O)(=O)=O)C2=C1 FNXKBSAUKFCXIK-UHFFFAOYSA-M 0.000 claims description 2
- 235000019372 spiramycin Nutrition 0.000 claims description 2
- 229960001294 spiramycin Drugs 0.000 claims description 2
- 229930191512 spiramycin Natural products 0.000 claims description 2
- 239000008107 starch Substances 0.000 claims description 2
- 235000019698 starch Nutrition 0.000 claims description 2
- 229960005322 streptomycin Drugs 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims description 2
- QPPBRPIAZZHUNT-UHFFFAOYSA-N sulfamerazine Chemical compound CC1=CC=NC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 QPPBRPIAZZHUNT-UHFFFAOYSA-N 0.000 claims description 2
- 229960002597 sulfamerazine Drugs 0.000 claims description 2
- 229940124530 sulfonamide Drugs 0.000 claims description 2
- 150000003456 sulfonamides Chemical class 0.000 claims description 2
- 239000000725 suspension Substances 0.000 claims description 2
- IWVCMVBTMGNXQD-UHFFFAOYSA-N terramycin dehydrate Natural products C1=CC=C2C(O)(C)C3C(O)C4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-UHFFFAOYSA-N 0.000 claims description 2
- 229960002180 tetracycline Drugs 0.000 claims description 2
- 235000019364 tetracycline Nutrition 0.000 claims description 2
- 229930101283 tetracycline Natural products 0.000 claims description 2
- SRTDKHGZQCTGBY-RVDKCFQWSA-N thiopeptin Chemical compound N1C2C(N=3)=CSC=3C(C(C)OC(=O)C=3N=C4C(O)C(NC(C(C)C)C(=O)NC(C)C(=O)NC(=C)C(=O)NC(C)C(=O)N5)C=CC4=C(C(C)O)C=3)NC(=S)C(N=3)=CSC=3C(C(C)(O)C(C)O)NC(=O)C(N=3)CSC=3C(=C/C)\NC(=O)C(C(C)O)NC(=O)C(N=3)=CSC=3C25CCC1C1=NC(C(N)=O)=CS1 SRTDKHGZQCTGBY-RVDKCFQWSA-N 0.000 claims description 2
- 108010030742 thiopeptin Proteins 0.000 claims description 2
- 229960001082 trimethoprim Drugs 0.000 claims description 2
- WBPYTXDJUQJLPQ-VMXQISHHSA-N tylosin Chemical compound O([C@@H]1[C@@H](C)O[C@H]([C@@H]([C@H]1N(C)C)O)O[C@@H]1[C@@H](C)[C@H](O)CC(=O)O[C@@H]([C@H](/C=C(\C)/C=C/C(=O)[C@H](C)C[C@@H]1CC=O)CO[C@H]1[C@@H]([C@H](OC)[C@H](O)[C@@H](C)O1)OC)CC)[C@H]1C[C@@](C)(O)[C@@H](O)[C@H](C)O1 WBPYTXDJUQJLPQ-VMXQISHHSA-N 0.000 claims description 2
- 229960004059 tylosin Drugs 0.000 claims description 2
- 235000019375 tylosin Nutrition 0.000 claims description 2
- OKEAMBAZBICIFP-UHFFFAOYSA-N 3-oxido-2,1,3-benzoxadiazol-3-ium Chemical compound C1=CC=CC2=[N+]([O-])ON=C21 OKEAMBAZBICIFP-UHFFFAOYSA-N 0.000 abstract description 2
- 239000003960 organic solvent Substances 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 15
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 9
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 4
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- RMVRSNDYEFQCLF-UHFFFAOYSA-N thiophenol Chemical compound SC1=CC=CC=C1 RMVRSNDYEFQCLF-UHFFFAOYSA-N 0.000 description 3
- AJGJUXSVUPXOHL-UHFFFAOYSA-N 2-nitro-5-phenylsulfanylaniline Chemical compound C1=C([N+]([O-])=O)C(N)=CC(SC=2C=CC=CC=2)=C1 AJGJUXSVUPXOHL-UHFFFAOYSA-N 0.000 description 2
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 239000005708 Sodium hypochlorite Substances 0.000 description 2
- ZPEIMTDSQAKGNT-UHFFFAOYSA-N chlorpromazine Chemical compound C1=C(Cl)C=C2N(CCCN(C)C)C3=CC=CC=C3SC2=C1 ZPEIMTDSQAKGNT-UHFFFAOYSA-N 0.000 description 2
- WASQWSOJHCZDFK-UHFFFAOYSA-N diketene Chemical compound C=C1CC(=O)O1 WASQWSOJHCZDFK-UHFFFAOYSA-N 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 229940005605 valeric acid Drugs 0.000 description 2
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- WBLZUCOIBUDNBV-UHFFFAOYSA-N 3-nitropropanoic acid Chemical compound OC(=O)CC[N+]([O-])=O WBLZUCOIBUDNBV-UHFFFAOYSA-N 0.000 description 1
- ZCWXYZBQDNFULS-UHFFFAOYSA-N 5-chloro-2-nitroaniline Chemical compound NC1=CC(Cl)=CC=C1[N+]([O-])=O ZCWXYZBQDNFULS-UHFFFAOYSA-N 0.000 description 1
- GNYWBJRDQHPSJL-UHFFFAOYSA-N 6-acetyl-6-hydroxycyclohexa-2,4-diene-1-carboxylic acid Chemical compound CC(=O)C1(O)C=CC=CC1C(O)=O GNYWBJRDQHPSJL-UHFFFAOYSA-N 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 229930192334 Auxin Natural products 0.000 description 1
- MQETZQLZTJUQHR-UHFFFAOYSA-N Auxin b Chemical compound CCC(C)C1CC(C(C)CC)C(C(O)CC(=O)CC(O)=O)=C1 MQETZQLZTJUQHR-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- SQFWJIUAWQYZCF-UHFFFAOYSA-N SC=1NC=CN1.OC1=C(OC=CC1=O)C Chemical compound SC=1NC=CN1.OC1=C(OC=CC1=O)C SQFWJIUAWQYZCF-UHFFFAOYSA-N 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000003674 animal food additive Substances 0.000 description 1
- 239000002363 auxin Substances 0.000 description 1
- RKOUCPMGBBKLNK-UHFFFAOYSA-N auxin a Chemical compound CCC(C)C1CC(C(C)CC)C(C(O)CC(O)C(O)C(O)=O)=C1 RKOUCPMGBBKLNK-UHFFFAOYSA-N 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229960001076 chlorpromazine Drugs 0.000 description 1
- 229960004022 clotrimazole Drugs 0.000 description 1
- VNFPBHJOKIVQEB-UHFFFAOYSA-N clotrimazole Chemical compound ClC1=CC=CC=C1C(N1C=NC=C1)(C=1C=CC=CC=1)C1=CC=CC=C1 VNFPBHJOKIVQEB-UHFFFAOYSA-N 0.000 description 1
- 230000002192 coccidiostatic effect Effects 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- YDEXUEFDPVHGHE-GGMCWBHBSA-L disodium;(2r)-3-(2-hydroxy-3-methoxyphenyl)-2-[2-methoxy-4-(3-sulfonatopropyl)phenoxy]propane-1-sulfonate Chemical compound [Na+].[Na+].COC1=CC=CC(C[C@H](CS([O-])(=O)=O)OC=2C(=CC(CCCS([O-])(=O)=O)=CC=2)OC)=C1O YDEXUEFDPVHGHE-GGMCWBHBSA-L 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- AOTWIFLKURJQGE-UHFFFAOYSA-N n-cyclopropylaniline Chemical compound C1CC1NC1=CC=CC=C1 AOTWIFLKURJQGE-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 230000000384 rearing effect Effects 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000004308 thiabendazole Substances 0.000 description 1
- 229960004546 thiabendazole Drugs 0.000 description 1
- 235000010296 thiabendazole Nutrition 0.000 description 1
- WJCNZQLZVWNLKY-UHFFFAOYSA-N thiabendazole Chemical compound S1C=NC(C=2NC3=CC=CC=C3N=2)=C1 WJCNZQLZVWNLKY-UHFFFAOYSA-N 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/50—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to ring nitrogen atoms
- C07D241/52—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/116—Heterocyclic compounds
- A23K20/137—Heterocyclic compounds containing two hetero atoms, of which at least one is nitrogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/12—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Polymers & Plastics (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Fodder In General (AREA)
Abstract
A novel quinoxaline derivative of the formula <IMAGE> is prepared by reacting a benzofuroxan of the formula <IMAGE> with acetoacetamide of the formula CH3COCH2-CO-NH-(CH2)2OH in the presence of ammonia or primary amines in an organic solvent which is inert to the reactants at temperatures from 30 DEG to 60 DEG C. The compound has useful properties for promoting the growth of domestic and productive animals. For use thereof in practice, it can be converted into compositions conforming to the application together with suitable auxiliaries. Thus, for example, it is suitable for use in a concentrated premix for mixing with a standard feed or in a finished final feed mixture.
Description
**WARNUNG** Anfang DESC Feld konnte Ende CLMS uberlappen **.
PATENTANSPRÜCHE
1. Verfahren zur Herstellung des Chinoxalin-di-N-oxids der Formeln
EMI1.1
dadurch gekennzeichnet dass man das Benzofuran der For meill
EMI1.2
und das Acetessigsäureamid der Formel III CH3COCH2-CO-NH-(CH2)2OH (III) in Gegenwart von Ammoniak oder primären Aminen in einem für die Reaktanden inerten organischen Lösungsmittel bei Temperaturen von 30 bis 60"C umsetzt.
2. Beifuttermittel, dadurch gekennzeichnet, dass es als Wirkstoff mindestens die Verbindung der Formel I gemäss Anspruch 1 zusammen mit inerten Trägerstoffen und/ oder Zusatzstoffen enthält.
3. Verfahren nach Anspruch 1, dadurch gekennzeichnet, dass es unter Ausschluss von Wasser durchgeführt wird.
Die vorliegende Erfindung betrifft ein Verfahren zur Herstellung eines neuen Chinoxalin-di-N-oxids mit wachstumfördernder Wirkung bei Haus- und Nutztieren, besonders beim Schwein sowie vorzugsweise bei Geflügel, und ein Beifuttermittel diese Verbindung enthaltend.
Das neue Chinoxalin-di-N-oxid entspricht folgender For mehl:
EMI1.3
Der Wirkstoff kann in Form von Lösungen, Emulsionen, Suspensionen, Pulvern, Pellets, Bolussen und Kapseln peroral, abomasal oder via Injektion den Tieren direkt und zwar als Einzeldosis wie auch wiederholt verabreicht werden. Der Wirkstoff bzw. ihn enthaltende Gemische können auch dem Futter oder den Tränken zugesetzt werden oder in sogenannten Futtervormischungen enthalten sein.
Das Chinoxalin-di-N-oxid-derivat der Formel I lässt sich entweder in Form einer konzentrierten Premix zur Vermischung mit einem Standardfutter oder als fertige Futtermischung, welche direkt an die Tiere verfüttert wird, anwenden.
Eine geeignete Premix ist z.B. eine Mischung des Chinoxa lin-di-N-oxid-derivates der Formel I mit Kaolin, Kalk, Aluminiumoxid, gemahlenen Muschelschalen, Bolus alba, Aerosil, Stärke oder Lactose.
Zur Herstellung einer Futtermischung, welche die aktive Komponente in einer Konzentration zwischen 1 und 500 ppm enthält, werden die nötigen Mengen der Premix mit der entsprechenden Menge eines handelsüblichen Standardfutters für Geflügel, für Schweine oder Wiederkäuer gründlich vermischt.
Der Futtermischung können noch weitere Stoffe die das Tiergewicht und Tierwachstum günstig beeinflussen, beigemischt werden.
1) Antibiotika z.B.
Penicillin (und deren Derivate) Cephalosprin (und deren Derivate) Chloroamphenicol Tetracycline Rifamizin Oxytetracyclin Nigericin P arvulin Spiramycin Flavomycin Neomycin Thiopeptin Tylosin Lincomycin Bacitracin (und deren Salze) Pyrrolnitrin Myxim Streptomycin 2) Sulfonamide z.B.
Sullisoxazol = N-(3,4-Dimethyl-5 -isoxazolyl)-sulfanylamid Sulfapyrazin = N-2-Pyrazinylsulfanylamid Sulfadimethoxidiazin = 2,4-Dimethoxy-6-sulfanylamido- 1,3- -diazin Sulfamerazin = N-(4-Methyl-2-pyrimidyl)-sulfanylamid 3) Nitrofuranez.B.
Furoxan = 3-(5-Nitrofurfurylidenamino)-2-oxazolidinon C arofur = 3-Amino-6-[2-(5-nitro-2-furyl)vinyl]pyridazin Altafur = 5-Morpholinomethyl-3-(5-nitrofurfurylidenami no)-2-oxazolidinon Payzon Nitrofurantoin Furacl antin Furazolidon 4) Diaminopyrimidine iB.
Trimethoprim = 2,4-Diamino-5-(3,4,5-trimethoxybenzyl)- -pyrimidin Dimethoprim = 2,4-Diamino-5-(3,4-dimethoxybenzyl)-pyri- midin Pyrimethamin = 2,4-Diamino-5-(p-chlorphenyl)-6-äthylpyri- midin 5) Hydroxychinolinez.B.
Sterosan = 5,7-Dichloro-2-methyl-8-quinolinol Vioform = 5-Chloro-7-iodo-S-quinolinol Hydroxychinolincarbonsäuren Hydrozynaphthyridincarb onsäuren Nalidixinsäure Oxolinsäure 6) halogenierte Hydroxydiphenylätherz.B.
Irgasan DP 300 = 2-Hydroxy-4,2',4'-trichlor-diphenyläther Nitrohydroxydiphenyläther halogenierte Salicylsäureanilide
Triarylmethylimidazole z.B.
Clotrimazol = Diphenyl-o-dichlorphenyl-imidazolyl( 1)-me- than Vitamine 3 -Hydroxy-2-methyl-4-pyron 2-Mercaptoimidazol äthoxylierte Alkohole 2-Brom-5-nitrothiazol
Guanidine N-subst.-Aminooxyessigsäuren ss-Nitropropionsäure Phenylcyclopropylamin Thiabendazol [2-(4-thiazolyl)-benzimidazol] Piperazin und deren Salze Benzodiazepionderivate Dihydroxydiphenylsulfide 4,5-Dihydroxy-2,4,6-octatriendicarbonsäuren 2-Formyl-4-chlorphenoxyessigsäuren geradkettige aliphatische Alkohole
Chlorpromazin [2-Chlor-10-(3-dimethylaminopropyl)-pheno- thiazin] Aspirin (2-Acetylsalicylsäure) A uxine z.B.
Auxin a = (3,5-di-sec.-Butyl-a,I3- d-trihydroxy-l -cyclopente nyl-valeriansäure) Auxin b = (3 ,5-di-sec.-Butyl-d-hydroxy-P-oxo- 1 -cyclopente nyl-valeriansäure); ebenfalls können Mineralsalze, Aminosäuren, wie auch An thelmintika oder Coccidiostatika beigemischt werden.
Das neue Chinoxalin-di-N-oxid-derivat besitzt ausgezeichnete wachstumfördernde Eigenschaften für die Aufzucht und Mast von Haus- und Nutztieren, besonders beim Schwein sowie vorzugsweise bei Geflügel.
Ähnliche Chinoxalin-di-N-oxid-verbindungen sind aus den deutschen Offenlegungsschriften Nr. 2 344314 und
1 670 935 bekannt.
Die Verbindung der Formel I wird erfindungsgemäss hergestellt, indem man das Benzofuroxan der Formel II
EMI2.1
und das Acetessigsäureamid der Formel III CH3COCH2-CO-NH(CH2)2OH (III) in Gegenwart von Ammoniak oder primären Aminen in einem für die Reaktanden inerten organischen Lösungsmittel bei Temperaturen von 30 bis 60"C umsetzt.
Es ist vorteilhaft die Reaktion unter Ausschluss von Wasser durchzuführen.
Als Lösungsmittel kommen z.B. Alkohole wie Methanol, Äthanol, Isopropanol oder Methylcellosolve in Betracht.
Der Ausgangsstoff der Formel II kann erhalten werden, indem man die Verbindung der Formel IV
EMI2.2
in Gegenwart von Kaliumhydroxid mit Natriumhypochlorit bei 10 bis 40"C, vorzugsweise bei 20"C, reagieren lässt.
Die Ausgangsverbindung der Formel III erhält man z.B. in bekannter Weise aus Diketen und Äthanolamin.
Beispiel Herstellung von 2-Met hy 1-3 -N-(ss- hydrnxyäthyl)-carbamoyl- -6-phenylthio-chinoxalin-1,4-di-N-oxid
In 200 ml Methanol, die auf-l0 bis OOC gekühlt werden, gibt man 13,6 g Äthanolamin. Dann tropft man unter Rühren bei -10 bis 0 C 18,5 g frisch destilliertes Diketen zu, lässt auf Raumtemperatur ansteigen und rührt noch 2 Std. bei 35"C.
Zur nun vorhandenen Lösung von Acetessigsäure- ss-hydroxy äthylamid gibt man 51,6 g 5-Phenylthiobenzofuroxan zu und leitet dann ca. 30 Mole Ammoniak ein, wobei die Reaktion anfangs exotherm ist und 450C nicht überschreiten soll. Nach Abklingen der Reaktionswärme erwärmt man auf 40 bis 45 "C und rührt 8 Std. nach, wobei sich das Reaktionsprodukt als hellgelber, kristalliner Niederschlag abscheidet. Man nutscht ab, wäscht mit Methanol aus und erhält 50 g (= 67,5% der Theorie) 2-Methyl-3-N-(ss-hydroxyäthyl)-carbamoyl-6-phe- nylthio-chinoxalin- 1 ,4-di-N-oxid als hellgelbe Kristalle, die nach dem Umkristallisieren aus Dimethylformamid/Äthanol bei 213-215"C schmelzen.
Das Ausgangsmaterial kann wie folgt hergestellt werden: a) 2 -Nitro-5-phenylthio.anilin
86 g 2-Nitro-5-chloranilin löst man in 400 ml Äthanol und erwärmt auf 700C Innentemperatur. Dazu tropft man eine Lö sung von 30,5 g Kaliumhydroxid und 60,5 g Thiophenol in 300 ml Äthanol. Die Reaktion verläuft exotherm. Anschliessend rührt man bei gleicher Innentemperatur über Nacht nach. Dann wird die erkaltete Mischung in Eiswasser eingerührt, der Niederschlag abgenutscht und aus Äthanol umkristallisiert. Man erhält 98,1 g (= 80% der Theorie) 2-Nitro-5 -phenylthioanilin vom Schmelzpunkt 115-117"C.
b) 5-Phenylthio-benzofuroxan
Zu einer Lösung von 5,6 g Kaliumhydroxid in 200 ml Äthanol und 12,3 g 2-Nitro-5-phenylthioanilin tropft man unter ständigem Rühren bei ca. 20"C Innentemperatur 60 ml Natriumhypochloritlösung (13%ig). Nach beendigter Zugabe rührt man h Std. nach, nutscht das ausgefallene Produkt ab und wäscht es mit 200 ml Wasser. Nach Umkristallisieren aus Äthanol erhält man 10 g (= 82% der Theorie) 5-Phenylthio -benzofuroxan vom Schmelzpunkt 79-800C.
Pastenförmige Wirkstofjkonzentrate
Solche halbfesten oder öligen Wirkstoffkonzentrate haben beispielsweise folgende Zusammensetzung: a) 40 Teile Wirkstoff
10 Teile Bolus alba
2 Teile Natrium-ligninsulfonat
0,2 Teile Natriumbenzoat
1,0 Teile Carboxymethylcellulose
46,8 Teile Wasser b) 30 Teile Wirkstoff
70 Teile Arachidöl (Erdnussöl)
Die Wirkstoffe werden mit den Trägerstoffen, Verteilungsmitteln und sonstigen Zusatzstoffen feinst (Teilchengrösse z.B.
5 bis 10 Mikron) vermahlen.
Die erhaltenen homogenen Konzentrate werden mittels einer Trankpistole an Haus- und Nutztieren verabreicht.
Futterzusatzmittel
Zur Herstellung von je 6000 Teilen Endfutter mit a) 25 ppm, b) 50 ppm, c) 200 ppm, d) 400 ppm wurden folgende Futtervormischungen hergestellt: a) 0,15 Teile Wirkstoff
49,85 Teile Bolus alba
150,0 Teile Standardfutter für Geflügel, Schweine oder
Wiederkäuer b) 0,30 Teile Wirkstoff
44,70 Teile Bolus alba
5,0 Teile Kieselsäure
150,0 Teile Standardfutter für Geflügel, Schweine oder
Wiederkäuer c) 1,2 Teile Wirkstoff
43,8 Teile Bolus alba
5,0 Teile Kieselsäure
150,0 Teile Standardfutter für Geflügel, Schweine oder
Wiederkäuer d) 2,4 Teile Wirkstoff
47,6 Teile Bolus alba
150,0 Teile Standardfutter für Geflügel, Schweine oder
Wiederkäuer
Die angegebenen Wirkstoffe werden entweder direkt den Trägerstoffen zugemischt oder z.B . in Chloroform gelöst auf die Trägerstoffe aufgezogen.
Anschliessend mahlt man zur gewünschten Teilchengrösse von zB. 5 bis 10 Mikron. Diese Futtervormischungen werden mit 5800 Teilen Standardfutter vermischt oder zu 6000 Teilen Fertigtränken verarbeitet. Ausserdem können diese Futtervormischungen zusammen mit 5800 Teilen Standardfutter pelletiert werden (Futterpellets).
Obgenannte Futtermischungen zeigen bei Huhn, Schwein und Wiederkäuer eine deutliche wachstumsteigernde Wirkung im Vergleich zu den Kontrolltieren, die mit den entsprechend gleichen Futtermischungen und Formen ohne Wirksubstanz gefüttert werden.
** WARNING ** beginning of DESC field could overlap end of CLMS **.
PATENT CLAIMS
1. Process for the preparation of the quinoxaline di-N-oxide of the formulas
EMI1.1
characterized in that the benzofuran from For meill
EMI1.2
and the acetoacetic acid amide of the formula III CH3COCH2-CO-NH- (CH2) 2OH (III) in the presence of ammonia or primary amines in an inert solvent for the reactants at temperatures of 30 to 60 "C.
2. Supplementary feed, characterized in that it contains as active ingredient at least the compound of formula I according to claim 1 together with inert carriers and / or additives.
3. The method according to claim 1, characterized in that it is carried out in the absence of water.
The present invention relates to a process for the production of a new quinoxaline di-N-oxide with growth-promoting action in domestic and farm animals, particularly in pigs and preferably in poultry, and a supplementary feed containing this compound.
The new quinoxaline di-N-oxide corresponds to the following flour:
EMI1.3
The active ingredient can be administered in the form of solutions, emulsions, suspensions, powders, pellets, boluses and capsules orally, abomasally or by injection directly to the animals, either as a single dose or repeatedly. The active ingredient or mixtures containing it can also be added to the feed or the drinkers or can be contained in so-called feed premixes.
The quinoxaline di-N-oxide derivative of the formula I can be used either in the form of a concentrated premix for mixing with a standard feed or as a finished feed mixture which is fed directly to the animals.
A suitable premix is e.g. a mixture of the quinoxa lin-di-N-oxide derivative of the formula I with kaolin, lime, aluminum oxide, ground mussel shells, bolus alba, aerosil, starch or lactose.
To produce a feed mixture that contains the active component in a concentration between 1 and 500 ppm, the necessary amounts of the premix are thoroughly mixed with the corresponding amount of a commercially available standard feed for poultry, pigs or ruminants.
The feed mixture can be mixed with other substances that have a beneficial effect on animal weight and growth.
1) antibiotics e.g.
Penicillin (and its derivatives) Cephalosprin (and its derivatives) Chloroamphenicol Tetracycline Rifamizin Oxytetracyclin Nigericin P arvulin Spiramycin Flavomycin Neomycin Thiopeptin Tylosin Lincomycin Bacitracin (and its salts) Pyrrolnitrin Myxim Streptomycin 2) Sulfonamides e.g.
Sullisoxazole = N- (3,4-dimethyl-5-isoxazolyl) sulfanylamide sulfapyrazine = N-2-pyrazinylsulfanylamide sulfadimethoxidiazine = 2,4-dimethoxy-6-sulfanylamido-1,3-diazine sulfamerazine = N- (4-methyl -2-pyrimidyl) sulfanylamide 3) nitrofuran, e.g.
Furoxan = 3- (5-Nitrofurfurylidenamino) -2-oxazolidinone C arofur = 3-Amino-6- [2- (5-nitro-2-furyl) vinyl] pyridazin Altafur = 5-Morpholinomethyl-3- (5-Nitrofurfurylidenami no ) -2-oxazolidinone Payzon Nitrofurantoin Furacl antin Furazolidon 4) Diaminopyrimidine iB.
Trimethoprim = 2,4-diamino-5- (3,4,5-trimethoxybenzyl) - pyrimidine Dimethoprim = 2,4-diamino-5- (3,4-dimethoxybenzyl) pyrimidine pyrimethamine = 2,4-diamino -5- (p-chlorophenyl) -6-ethylpyrimidine 5) hydroxyquinolines e.g.
Sterosan = 5,7-dichloro-2-methyl-8-quinolinol Vioform = 5-chloro-7-iodo-S-quinolinol
Irgasan DP 300 = 2-hydroxy-4,2 ', 4'-trichloro-diphenyl ether, nitrohydroxydiphenyl ether, halogenated salicylic acid anilides
Triarylmethylimidazoles e.g.
Clotrimazole = Diphenyl-o-dichlorophenyl-imidazolyl (1) -meta- than Vitamins 3 -Hydroxy-2-methyl-4-pyrone 2-Mercaptoimidazole ethoxylated alcohols 2-bromo-5-nitrothiazole
Guanidines N-subst.-aminooxyacetic acids ss-nitropropionic acid phenylcyclopropylamine thiabendazole [2- (4-thiazolyl) -benzimidazole] piperazine and its salts benzodiazepione derivatives dihydroxydiphenyl sulfides 4,5-dihydroxy-2,4,6-octatrienedicarboxylic acids 2-formyl acetic acid 4-formyl acetic acid 2-formyl acetic acid 4-formyl acetic acid 2-formyl acetic acid aliphatic alcohols
Chlorpromazine [2-chloro-10- (3-dimethylaminopropyl) phenothiazine] aspirin (2-acetylsalicylic acid) auxins e.g.
Auxin a = (3,5-di-sec.-butyl-a, I3-d-trihydroxy-l -cyclopente nyl-valeric acid) Auxin b = (3,5-di-sec.-butyl-d-hydroxy-P -oxo- 1 -cyclopente nyl-valeric acid); Mineral salts, amino acids, as well as thelmintics or coccidiostatics can also be added.
The new quinoxaline di-N-oxide derivative has excellent growth-promoting properties for the rearing and fattening of domestic and farm animals, especially in pigs and preferably poultry.
Similar quinoxaline di-N-oxide compounds are known from German Offenlegungsschriften No. 2 344314 and
1,670,935.
The compound of formula I is prepared according to the invention by the benzofuroxane of formula II
EMI2.1
and the acetoacetic acid amide of the formula III CH3COCH2-CO-NH (CH2) 2OH (III) in the presence of ammonia or primary amines in an inert solvent for the reactants at temperatures of 30 to 60 "C.
It is advantageous to carry out the reaction in the absence of water.
Examples of solvents are Alcohols such as methanol, ethanol, isopropanol or methyl cellosolve into consideration.
The starting material of formula II can be obtained by using the compound of formula IV
EMI2.2
in the presence of potassium hydroxide with sodium hypochlorite at 10 to 40 "C, preferably at 20" C, can react.
The starting compound of formula III is obtained e.g. in a known manner from diketene and ethanolamine.
Example Preparation of 2-Met hy 1-3 -N- (ss- hydrnxyäthyl) -carbamoyl- -6-phenylthio-quinoxaline-1,4-di-N-oxide
13.6 g of ethanolamine are added to 200 ml of methanol, which are cooled to −10 to OOC. Then 18.5 g of freshly distilled diketene are added dropwise at -10 to 0 ° C., the mixture is allowed to rise to room temperature and the mixture is stirred for a further 2 hours at 35 ° C.
51.6 g of 5-phenylthiobenzofuroxane are then added to the solution of acetoacetic acid-ss-hydroxyethylamide present and then about 30 moles of ammonia are passed in, the reaction initially being exothermic and not to exceed 450 ° C. After the heat of reaction has subsided, the mixture is warmed to 40 to 45 ° C. and stirred for a further 8 hours, during which the reaction product separates out as a light yellow, crystalline precipitate. The product is filtered off, washed with methanol and 50 g (= 67.5% of theory) ) 2-Methyl-3-N- (ss-hydroxyethyl) -carbamoyl-6-phenylthio-quinoxaline-1,4-di-N-oxide as light yellow crystals, which after recrystallization from dimethylformamide / ethanol at 213-215 "C melt.
The starting material can be prepared as follows: a) 2-nitro-5-phenylthio.aniline
86 g of 2-nitro-5-chloroaniline are dissolved in 400 ml of ethanol and heated to an internal temperature of 700C. A solution of 30.5 g of potassium hydroxide and 60.5 g of thiophenol in 300 ml of ethanol is added dropwise. The reaction is exothermic. Then the mixture is stirred overnight at the same internal temperature. The cooled mixture is then stirred into ice water, the precipitate is filtered off and recrystallized from ethanol. 98.1 g (= 80% of theory) of 2-nitro-5-phenylthioaniline with a melting point of 115-117 ° C. are obtained.
b) 5-phenylthio-benzofuroxane
60 ml of sodium hypochlorite solution (13% strength) are added dropwise to a solution of 5.6 g of potassium hydroxide in 200 ml of ethanol and 12.3 g of 2-nitro-5-phenylthioaniline with constant stirring at an internal temperature of about 20 ° C. After stirring, the mixture is stirred After one hour, the precipitated product is filtered off with suction and washed with 200 ml of water. After recrystallization from ethanol, 10 g (= 82% of theory) of 5-phenylthio-benzofuroxane with a melting point of 79-800 ° C. are obtained.
Paste-like active ingredient concentrates
Such semi-solid or oily active ingredient concentrates have, for example, the following composition: a) 40 parts of active ingredient
10 parts bolus alba
2 parts of sodium lignin sulfonate
0.2 parts sodium benzoate
1.0 parts carboxymethyl cellulose
46.8 parts of water b) 30 parts of active ingredient
70 parts arachid oil (peanut oil)
The active ingredients are very fine with the carriers, distribution agents and other additives (particle size e.g.
5 to 10 microns).
The homogeneous concentrates obtained are administered to domestic and farm animals using a feed gun.
Feed additives
The following feed premixes were produced for the production of 6000 parts of final feed with a) 25 ppm, b) 50 ppm, c) 200 ppm, d) 400 ppm: a) 0.15 part of active ingredient
49.85 parts bolus alba
150.0 parts of standard feed for poultry, pigs or
Ruminants b) 0.30 parts of active ingredient
44.70 parts bolus alba
5.0 parts of silica
150.0 parts of standard feed for poultry, pigs or
Ruminants c) 1.2 parts of active ingredient
43.8 parts bolus alba
5.0 parts of silica
150.0 parts of standard feed for poultry, pigs or
Ruminants d) 2.4 parts of active ingredient
47.6 parts bolus alba
150.0 parts of standard feed for poultry, pigs or
ruminant
The specified active ingredients are either added directly to the carriers or e.g. dissolved in chloroform on the carriers.
Then grinding to the desired particle size of, for example. 5 to 10 microns. These feed premixes are mixed with 5800 parts standard feed or processed into 6000 parts ready-to-drink. In addition, these feed premixes can be pelletized together with 5800 parts of standard feed (feed pellets).
The above-mentioned feed mixtures show a significant growth-increasing effect in chicken, pork and ruminants compared to the control animals which are fed with the corresponding feed mixtures and forms without active substance.
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH39276A CH619458A5 (en) | 1976-01-14 | 1976-01-14 | Process for the preparation of a quinoxaline derivative |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH39276A CH619458A5 (en) | 1976-01-14 | 1976-01-14 | Process for the preparation of a quinoxaline derivative |
Publications (1)
Publication Number | Publication Date |
---|---|
CH619458A5 true CH619458A5 (en) | 1980-09-30 |
Family
ID=4185964
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH39276A CH619458A5 (en) | 1976-01-14 | 1976-01-14 | Process for the preparation of a quinoxaline derivative |
Country Status (1)
Country | Link |
---|---|
CH (1) | CH619458A5 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000001669A2 (en) * | 1998-07-01 | 2000-01-13 | Bayer Aktiengesellschaft | Method for preparing 2-nitro-5-(phenylthio)-anilines |
-
1976
- 1976-01-14 CH CH39276A patent/CH619458A5/en not_active IP Right Cessation
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000001669A2 (en) * | 1998-07-01 | 2000-01-13 | Bayer Aktiengesellschaft | Method for preparing 2-nitro-5-(phenylthio)-anilines |
WO2000001669A3 (en) * | 1998-07-01 | 2000-02-10 | Bayer Ag | Method for preparing 2-nitro-5-(phenylthio)-anilines |
US6552230B1 (en) | 1998-07-01 | 2003-04-22 | Bayer Aktiengesellschaft | Method for preparing 2-nitro-5-(phenylthio)-anilines |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE2344314A1 (en) | HETEROCYCLIC COMPOUNDS | |
CH619458A5 (en) | Process for the preparation of a quinoxaline derivative | |
EP0209025B1 (en) | Arylethanolhydroxyl amines, process for their preparation and their use in promoting productivity | |
CH512887A (en) | Quinoline derivs antibacterial coccidiostatic | |
DE1470205B1 (en) | 5-Nitropyrrole derivatives and process for their preparation | |
CH619460A5 (en) | Process for the preparation of quinoxaline di-N-oxide derivatives | |
CH619457A5 (en) | Process for the preparation of a quinoxaline derivative | |
CH619456A5 (en) | Process for the preparation of quinoxaline di-N-oxide derivatives | |
DE2701707C2 (en) | Quinoxaline di-N-oxide derivatives | |
DD266264A5 (en) | AGENTS FOR PERFORMANCE OF ANIMALS | |
EP0012725B1 (en) | Quinoxaline-di-n-oxide derivatives, process for their preparation, compositions containing them and their use | |
DE2905641A1 (en) | ACTIVE SUBSTANCES AND CONTAINERS THEREOF FOR USE IN THE TREATMENT OF MAMMALS FOR CONTROLLING PARASITAL DIPTERE LARVES | |
CH619698A5 (en) | Process for the preparation of quinoxaline-di-N-oxide derivatives | |
CH619459A5 (en) | Process for the preparation of quinoxaline di-N-oxide derivatives | |
DE1935338C2 (en) | Isothiocyano-diphenylamines, processes for their preparation and an anthelmintic agent containing these compounds | |
DE2905667A1 (en) | ACTIVE SUBSTANCES AND CONTAINERS THEREOF FOR USE IN THE TREATMENT OF MAMMALS FOR CONTROLLING PARASITAL DIPTERE LARVES | |
CH648025A5 (en) | CHINOXALINE-1,4-DIOXYD DERIVATIVES. | |
DE2800764A1 (en) | ANTHELMINTICA | |
AT332413B (en) | PROCESS FOR THE PREPARATION OF NEW QUINOXALIN-DI-N-OXIDE DERIVATIVES | |
AT230380B (en) | Process for the preparation of new 4-sulfanilamido-6-substituted pyrimidines and their alkali salts | |
DE1470053C (en) | S ^ -Diamino-ö-chloropyrazinoylguanidines, their salts and process for their preparation | |
DE2501875A1 (en) | ALKYLSULFONYLMETHYL AND ALKYLSULFINYLMETHYLCHINOXALIN-1,4-DIOXIDE | |
AT367296B (en) | METHOD FOR THE CURATIVE AND PROPHYLACTIC FIGHTING OF PARASITAL HELMINTHS | |
DE2120501A1 (en) | New quinoxaline derivatives | |
DE1493513A1 (en) | New anthranilic acid derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PL | Patent ceased | ||
PL | Patent ceased |